Parliament Workbench
Data: Motions & questions to 19 Nov 2026 · Votes to 12 Nov 2026

Members' Business Motion · S5M-13020 · Session 5

Precision Medicine

Lodged by Alexander Stewart Con Lodged 27 Jun 2018 18 supporters

The motion

That the Parliament welcomes the rapid development of precision medicine, which is a medical model that proposes the customisation of healthcare, with medical decisions, treatments, practices or products being genetically tailored to the individual patient; acknowledges that, with this model, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis; notes that tools employed in precision medicine can include molecular diagnostics, imaging and analytics; further notes that this does not mean that the creation of drugs or medical devices are unique to a patient but rather the ability to classify individuals into subpopulations, which differ in their susceptibility to a particular disease, or in the biology or prognosis of diseases that they may develop such as cancer, or in their response to a specific treatment; acknowledges that preventive or therapeutic interventions may then be concentrated on those who will potentially benefit, thus sparing expense and side effects for those who will not; considers that, on the treatment side, precision medicine can involve the use of customised medical products such as drug mixes produced by pharmacy compounding or customised devices; is aware that this technique can prevent harmful drug interactions, increase overall efficiency when prescribing medications and reduce costs associated with healthcare; understands that artificial intelligence (AI) provides an example of the shift toward precision medicine, with machine-learning algorithms being used for genomic sequences and for analysing and drawing inferences from the vast amounts of data that patients and healthcare institutions have recorded; is encouraged by AI techniques already being used with success in precision cardiovascular medicine to understand genotypes and phenotypes in existing diseases, and is enthused by what it considers the enormous potential of precision medicine in all disciplines to vastly improve the quality of healthcare for patients in the Mid Scotland and Fife region and across Scotland, and to enable cost-effectiveness and a reduction in patient readmission and mortality rates.

Signatures by party

18 MSPs besides the lodger · 0 from other parties
Con 18

Party on the day each MSP signed. Signing a motion is voluntary and not whipped. Who signs whose motions

Vote

No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.

Supporters

18 MSPs

Con 18

Show all 18 supporters by party

Con 18

Party shown is each supporter’s party when the motion was published.

In the Official Report

No contribution in the Official Report cites S5M-13020 by reference.